Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2006-11-14
2006-11-14
Rao, Deepak (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S235800, C514S252140, C514S269000, C514S272000, C544S003000, C544S122000, C544S295000, C544S311000, C544S319000, C544S320000
Reexamination Certificate
active
07135467
ABSTRACT:
Compounds useful for treating HIV are disclosed having the general formulawherein R1, R2, and B are as defined in the specification. Compositions containing the compounds and methods for using the compounds to inhibit HIV are also disclosed.
REFERENCES:
patent: 6096753 (2000-08-01), Spohr et al.
patent: 2005/0025774 (2005-02-01), Crescenzi et al.
patent: 2005/0075356 (2005-04-01), Di Francesco et al.
patent: 2005/0261322 (2005-11-01), Naidu et al.
patent: 2006/0046985 (2006-03-01), Crescenzi et al.
patent: 1422218 (2004-05-01), None
patent: WO 02/06246 (2002-01-01), None
patent: WO 03/035077 (2003-05-01), None
patent: WO 2003/062211 (2003-07-01), None
patent: WO 2005/061490 (2005-07-01), None
patent: WO 2005/061501 (2005-07-01), None
patent: WO 2005/070901 (2005-08-01), None
Miles et al., Medline Abstract (The growing of HIV pandemic, Community Pract vol. 78, Issue 8, pp. 292-294) Aug. 2005.
Johnson et al., CAPLUS Abstract 23:16245, 1929.
Marcus et al., PubMed Abstract (Intervirology, 45(4-6):260-6), 2002.
van Heeswijk et al., PubMed Abstract (Antivir Ther 6(4):201-29) Dec. 2001.
Vippagunta et al., Cyrstalline Solids, Advanced Drug Delivery Reviews, 48, pp. 3-26, 2001.
West, Solid Solutions, Solid State Chemistry and its applications, pp. 358 & 365, 1988.
Ulrich, Chapter 4: Crystallization, Kirk-Othmer Encyclopedia of Chemical Technology, Aug. 2002.
Silverman, Prodrugs and Drug Delivery Systems, The Organic Chemistry of Drug Design and Drug Action, pp. 352-400, 1992.
Bundgaard, Design of Produgs: Bioreversible derivatives for various functional groups and chemical entities, pp. 1, 1995.
Sunderland et al. (2001) Inorganic Chemistry, vol. 40, pp. 6746-6756.
Neamati et al. (1997) Drug Discovery Today, vol. 2, No. 11, pp. 487-498.
T. P. Culbertson, “Synthesis of 5,6-Dihydroxy-2-Phenyl-4-Pyrimidinecarboxylic Acid, Methyl Ester, a Corrected Structure,” J. Heterocyclic Chem. 16, pp. 1423-1424, 1979.
S. D. Dreher, et al, “Highly Selective Synthesis of 2-Substituted-5-Hydroxy-6-Oxo-1,6-Dihydropyrimidine-4-Carboxylic Acid Derivatives Using a Novel Protected Dihydroxyfumarate,” Tetrahedron Letters, 45, pp. 6023-6025, 2004.
Gulgeze Hatice Belgin
Matiskella John
Naidu Narasimhulu B.
Sorenson Margaret E.
Ueda Yasutsugu
Bristol--Myers Squibb Company
Epperson James
Rao Deepak
Volles Warren K.
LandOfFree
HIV integrase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with HIV integrase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and HIV integrase inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3681062